Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Carrier-free (BSA/glycerol-free) PRKCE mouse monoclonal antibody, clone OTI2A12 (formerly 2A12)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) NRBP1 mouse monoclonal antibody, clone OTI5C3 (formerly 5C3)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Reactivities
- Monkey
Isotypes
- IgG2b
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Families
- Protein Kinase
Brands
- TrueMAB
Filter by
Category
Target Symbol
Antibody Hosts
Carrier-free
Knockout (KO) Validation
Pathways
- Fc epsilon RI signaling pathway (78)
- MAPK signaling pathway (69)
- GnRH signaling pathway (66)
- Toll-like receptor signaling pathway (66)
- Fc gamma R-mediated phagocytosis (45)
- Vascular smooth muscle contraction (42)
- Progesterone-mediated oocyte maturation (39)
- Amyotrophic lateral sclerosis (ALS) (36)
- Neurotrophin signaling pathway (36)
- T cell receptor signaling pathway (36)
- VEGF signaling pathway (36)
- Oocyte meiosis (33)
- Pathways in cancer (33)
- Prostate cancer (33)
- Regulation of actin cytoskeleton (33)
- Acute myeloid leukemia (30)
- B cell receptor signaling pathway (30)
- Bladder cancer (30)
- Chemokine signaling pathway (30)
- Chronic myeloid leukemia (30)
- Colorectal cancer (30)
- Dorso-ventral axis formation (30)
- Endometrial cancer (30)
- ErbB signaling pathway (30)
- Focal adhesion (30)
- Gap junction (30)
- Glioma (30)
- Insulin signaling pathway (30)
- Long-term depression (30)
- Long-term potentiation (30)
- Melanogenesis (30)
- Melanoma (30)
- Natural killer cell mediated cytotoxicity (30)
- Non-small cell lung cancer (30)
- Pancreatic cancer (30)
- Prion diseases (30)
- Renal cell carcinoma (30)
- Thyroid cancer (30)
- Tight junction (12)
- Type II diabetes mellitus (12)
- Cell cycle (6)
- Epithelial cell signaling in Helicobacter pylori infection (6)
- Leukocyte transendothelial migration (6)
- NOD-like receptor signaling pathway (6)
- RIG-I-like receptor signaling pathway (6)
- p53 signaling pathway (6)
- Axon guidance (3)
- Small cell lung cancer (3)